|
1
|
Jiang YN, Tan M, He C, Wang J, Wei Y, Jing N, Wang B, Yang F, Zhang Y, Li M. Supramolecular Switch for the Regulation of Antibacterial Efficacy of Near-Infrared Photosensitizer. Molecules 2024; 29:1040. [PMID: 38474550 DOI: 10.3390/molecules29051040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2024] [Revised: 02/22/2024] [Accepted: 02/26/2024] [Indexed: 03/14/2024] Open
Abstract
The global antibiotic resistance crisis has drawn attention to the development of treatment methods less prone to inducing drug resistance, such as antimicrobial photodynamic therapy (aPDT). However, there is an increasing demand for new photosensitizers capable of efficiently absorbing in the near-infrared (NIR) region, enabling antibacterial treatment in deeper sites. Additionally, advanced strategies need to be developed to avert drug resistance stemming from prolonged exposure. Herein, we have designed a conjugated oligoelectrolyte, namely TTQAd, with a donor-acceptor-donor (D-A-D) backbone, enabling the generation of reactive oxygen species (ROS) under NIR light irradiation, and cationic adamantaneammonium groups on the side chains, enabling the host-guest interaction with curcubit[7]uril (CB7). Due to the amphiphilic nature of TTQAd, it could spontaneously form nanoassemblies in aqueous solution. Upon CB7 treatment, the positive charge of the cationic adamantaneammonium group was largely shielded by CB7, leading to a further aggregation of the nanoassemblies and a reduced antibacterial efficacy of TTQAd. Subsequent treatment with competitor guests enables the release of TTQAd and restores its antibacterial effect. The reversible supramolecular switch for regulating the antibacterial effect offers the potential for the controlled release of active photosensitizers, thereby showing promise in preventing the emergence of drug-resistant bacteria.
Collapse
Affiliation(s)
- Yu-Na Jiang
- Cixi Biomedical Research Institute, Wenzhou Medical University, Ningbo 315302, China
- Ningbo Key Laboratory of Biomedical Imaging Probe Materials and Technology, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo 315201, China
| | - Manqi Tan
- Cixi Biomedical Research Institute, Wenzhou Medical University, Ningbo 315302, China
- Ningbo Key Laboratory of Biomedical Imaging Probe Materials and Technology, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo 315201, China
| | - Chenglong He
- Cixi Biomedical Research Institute, Wenzhou Medical University, Ningbo 315302, China
- Ningbo Key Laboratory of Biomedical Imaging Probe Materials and Technology, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo 315201, China
| | - Jiaxi Wang
- School of Materials Science and Engineering, University of Science and Technology Beijing, Beijing 100083, China
| | - Yi Wei
- School of Materials Science and Engineering, University of Science and Technology Beijing, Beijing 100083, China
| | - Ningning Jing
- College of Science and Technology, Ningbo University, Ningbo 315300, China
| | - Bing Wang
- Ningbo Key Laboratory of Biomedical Imaging Probe Materials and Technology, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo 315201, China
- Zhejiang International Scientific and Technological Cooperative Base of Biomedical Materials and Technology, Ningbo Cixi Institute of Biomedical Engineering, Ningbo 315300, China
| | - Fang Yang
- Cixi Biomedical Research Institute, Wenzhou Medical University, Ningbo 315302, China
- Ningbo Key Laboratory of Biomedical Imaging Probe Materials and Technology, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo 315201, China
- Zhejiang International Scientific and Technological Cooperative Base of Biomedical Materials and Technology, Ningbo Cixi Institute of Biomedical Engineering, Ningbo 315300, China
| | - Yujie Zhang
- Cixi Biomedical Research Institute, Wenzhou Medical University, Ningbo 315302, China
- Ningbo Key Laboratory of Biomedical Imaging Probe Materials and Technology, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo 315201, China
- Zhejiang International Scientific and Technological Cooperative Base of Biomedical Materials and Technology, Ningbo Cixi Institute of Biomedical Engineering, Ningbo 315300, China
| | - Meng Li
- Ningbo Key Laboratory of Biomedical Imaging Probe Materials and Technology, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo 315201, China
- Zhejiang International Scientific and Technological Cooperative Base of Biomedical Materials and Technology, Ningbo Cixi Institute of Biomedical Engineering, Ningbo 315300, China
| |
Collapse
|
|
2
|
Ruan YR, Li WZ, Ye YY, Luo J, Xu SY, Xiao J, Lin XW, Liu S, Wang XQ, Wang W. Supramolecularly assisted chlorhexidine-bacterial membrane interaction with enhanced antibacterial activity and reduced side effects. J Colloid Interface Sci 2023; 641:146-154. [PMID: 36931213 DOI: 10.1016/j.jcis.2023.03.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2023] [Revised: 02/26/2023] [Accepted: 03/02/2023] [Indexed: 03/09/2023]
Abstract
Bacterial infection has emerged as a grievous threat to public health, and lots of antibacterial agents were developed to solve this issue. However, enhancing the antibacterial activity of antibacterial agents while reducing their side effects remains a challenge. Herein, a supramolecular antibacterial agent based on the host-guest interaction between cucurbit[7]uril (CB[7]) and chlorhexidine (CHX) was designed. CHX can be encapsulated in the cavity of CB[7] to form a 1:3 host-guest complex (CHX-3CB[7]). It was amazingly found that this supramolecular complex could display higher antibacterial activity than CHX alone. Electrospray mass spectrometry and UV-vis spectra revealed that the introduction of CB[7] promoted the protonation of N-atoms on CHX, resulting in stronger ion interaction with phospholipids and thus enhancing the destruction of the bacterial membrane. Scanning electron microscopy (SEM), surface ζ-potentials and outer/inner membrane integrity assays also reveal that the introduction of CB[7] aggravates the rupture of membrane. What is more, the cytotoxicity and irritation of CHX were decreased by forming the host-guest complex with CB[7]. This work provides a paradigm for enhancing antibacterial activity and reducing side effects of drugs through supramolecular chemistry.
Collapse
Affiliation(s)
- Yi-Ru Ruan
- School of Chemistry and Chemical Engineering, Wuhan University of Science and Technology, Wuhan 430081, China.
| | - Wen-Zhen Li
- School of Chemistry and Chemical Engineering, Wuhan University of Science and Technology, Wuhan 430081, China.
| | - Yu-Yuan Ye
- School of Chemistry and Chemical Engineering, Wuhan University of Science and Technology, Wuhan 430081, China.
| | - Jie Luo
- School of Chemistry and Chemical Engineering, Wuhan University of Science and Technology, Wuhan 430081, China.
| | - Shi-Yuan Xu
- School of Chemistry and Chemical Engineering, Wuhan University of Science and Technology, Wuhan 430081, China.
| | - Ju Xiao
- School of Chemistry and Chemical Engineering, Wuhan University of Science and Technology, Wuhan 430081, China.
| | - Xiao-Wei Lin
- School of Chemistry and Chemical Engineering, Wuhan University of Science and Technology, Wuhan 430081, China.
| | - Simin Liu
- School of Chemistry and Chemical Engineering, Wuhan University of Science and Technology, Wuhan 430081, China.
| | - Xiao-Qiang Wang
- School of Chemistry and Chemical Engineering, Wuhan University of Science and Technology, Wuhan 430081, China.
| | - Wenjing Wang
- School of Chemistry and Chemical Engineering, Wuhan University of Science and Technology, Wuhan 430081, China.
| |
Collapse
|
|
3
|
Aktanova A, Abramova T, Pashkina E, Boeva O, Grishina L, Kovalenko E, Kozlov V. Assessment of the Biocompatibility of Cucurbiturils in Blood Cells. NANOMATERIALS 2021; 11:nano11061356. [PMID: 34063763 PMCID: PMC8223778 DOI: 10.3390/nano11061356] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/30/2021] [Revised: 05/18/2021] [Accepted: 05/19/2021] [Indexed: 12/29/2022]
Abstract
Currently, cucurbiturils are being actively researched all over the world. Research is focused on the ways of improving the solubility and selectivity of cucurbiturils, increasing the stability of the complexes with other particles in various media and enhancing their ability to bind and release various substances. The most significant area of our research is the assessment of safety, studying the biological properties and synergistic effects of cucurbiturils during complexation with drugs. In this article, the hemocompatibility of erythrocytes and leukocytes with cucurbiturils was investigated. We demonstrated that cucurbiturils have no cytotoxic effect, even at high concentrations (1 mM) and do not affect the viability of PBMCs. However, cucurbiturils can increase the level of the early apoptosis of lymphocytes and cucurbit[7]uril enhances hemolysis in biologically relevant media. Despite this, cucurbiturils are fairly safe organic molecules in concentrations up to 0.3 mM. Thus, we believe that it will become possible to use polymer nanostructures as drug delivery systems in clinical practice, since cucurbiturils can be modified to improve pharmacological properties.
Collapse
Affiliation(s)
- Alina Aktanova
- Research Institute of Fundamental and Clinical Immunology, 6300099 Novosibirsk, Russia; (A.A.); (T.A.); (O.B.); (L.G.); (V.K.)
| | - Tatjana Abramova
- Research Institute of Fundamental and Clinical Immunology, 6300099 Novosibirsk, Russia; (A.A.); (T.A.); (O.B.); (L.G.); (V.K.)
| | - Ekaterina Pashkina
- Research Institute of Fundamental and Clinical Immunology, 6300099 Novosibirsk, Russia; (A.A.); (T.A.); (O.B.); (L.G.); (V.K.)
- Correspondence:
| | - Olga Boeva
- Research Institute of Fundamental and Clinical Immunology, 6300099 Novosibirsk, Russia; (A.A.); (T.A.); (O.B.); (L.G.); (V.K.)
- Department of Medicine, Novosibirsk State University, 630090 Novosibirsk, Russia
| | - Lyubov Grishina
- Research Institute of Fundamental and Clinical Immunology, 6300099 Novosibirsk, Russia; (A.A.); (T.A.); (O.B.); (L.G.); (V.K.)
| | - Ekaterina Kovalenko
- Nikolaev Institute of Inorganic Chemistry SB RAS, 630090 Novosibirsk, Russia;
| | - Vladimir Kozlov
- Research Institute of Fundamental and Clinical Immunology, 6300099 Novosibirsk, Russia; (A.A.); (T.A.); (O.B.); (L.G.); (V.K.)
| |
Collapse
|